BARRX Medical closes $15 million Series D financing BARRX Medical.

Today announced the closing of a $15 million Series D financing, that was led by fresh investor Highland Capital Companions and became a member of by existing traders Delphi Ventures, Alloy Ventures, Frazier Health care Ventures, Sutter Hill Ventures, Greenspring others and Associates. Develops endoscopic treatment solutions for dealing with precancerous lesions of the esophagus along with other chronic gastrointestinal illnesses. Related StoriesCrucial modification in single DNA bottom predisposes children to intense form of cancerMeat-rich diet plan may increase kidney tumor riskNew antenna-like gadget makes breast cancer medical procedures less complicated for surgeons’We welcome Highland Capital Companions as our newest trader in BARRX and also the addition of Bijan Salehizadeh, M.D.Preliminary accreditation is certainly a five-year process which includes a step-wise progression towards full implementation and maintenance of the 30 programmatic standards. Programs are required to submit annual reviews reflecting progress towards complete compliance and in the fourth year undergo a niche site visit prior to receiving accreditation. Related StoriesCWRU awarded two NIH grants to produce pathology picture informatics platformNew network created to provide area-wide look after lung cancer sufferers in Northern GermanyUCSF-led experts map out melanoma's genetic trajectories’Strengths of this program include the relationship that it offers with the city and the array of clinical experiences that we offer our college students,’ said Moineau.